ALLR insider filings
Allarity Therapeutics, Inc. — 19 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-09. Screen ALLR transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Graff Jeremy R. — See Remarks | 1 | — | — | 6 |
Recent insider filings — Allarity Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-09 | 4 | Graff Jeremy R. — See Remarks | Option exercise (M): 48,147 · Tax withholding (F): 17,814 @ $1.18 · Option exercise (M): 39,494 · Tax withholding (F): 14,613 @ $0.97 · Option exercise (M): 48,147 (derivative) @ $0 · Option exercise (M): 39,494 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Jensen Thomas — CEO | Grant/award (A): 200,000 @ $0 | EDGAR |
| 2026-05-11 | 4 | Hoeiland Jesper — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-05-07 | 4 | McLaughlin Gerald W. — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2026-04-30 | 4/A | Graff Jeremy R. — See Remarks | Grant/award (A): 133,333 @ $0 | EDGAR |
| 2026-04-30 | 4 | Ervin Jeffrey S — CFO | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2026-01-16 | 4 | Graff Jeremy R. — See Remarks | Grant/award (A): 133,333 @ $0 | EDGAR |
| 2025-10-02 | 4 | Graff Jeremy R. — See Remarks | Option exercise (M): 39,494 · Tax withholding (F): 14,613 @ $1.58 · Option exercise (M): 39,494 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Graff Jeremy R. — CDO | Grant/award (A): 144,441 @ $0 | EDGAR |
| 2025-01-24 | 4 | Epshinsky Alexander — CFO | Grant/award (A): 29,496 @ $0 | EDGAR |
| 2025-01-24 | 4 | Jensen Thomas — CEO | Grant/award (A): 396,734 @ $0 | EDGAR |
| 2025-01-24 | 4 | Benjamin Laura — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4/A | Benjamin Laura — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Vazzano Joseph Walter — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4/A | Vazzano Joseph Walter — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | McLaughlin Gerald W. — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4/A | McLaughlin Gerald W. — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | Graff Jeremy R. — See Remarks | Grant/award (A): 118,483 @ $2.11 | EDGAR |
| 2022-07-14 | 4 | Knudsen Jens Erik — Former Chief Financial Officer | Holdings only — no transactions reported | EDGAR |
Recent 8-K events — Allarity Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-19 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-30 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2026-10-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALLR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs